---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016681"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T18:32:04.327731+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# eXoZymes to receive $3M from NSF as key partner in $9.2M cell-free biomanufacturing initiative

## Summary
- Selected as core industrial partner in Meta-PURE, a $9.2M NSF-funded project under CFIRE program.
- eXoZymes awarded approximately $3M share to develop a cell-free ATP-generating module and a santalene production module.
- Project led by Georgia Tech; coalition includes academic and industry groups; starts July 1, 2025, for three years.
- eXoZymes' technology enables plug-and-play modular cell-free biomanufacturing for multiple market-relevant targets.

## SEC filing metadata
- accession: 0001641172-25-016681
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/0001641172-25-016681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016681
- JSON: https://secwatch.observer/filing/0001641172-25-016681.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016681.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.